Annual Review Course (2023)

Austin, TX US
June 2, 2023 to June 4, 2023

The AUA will abide by and follow all CDC guidelines, as well as state, local and federal regulations. Please check the "Venue" tab for additional guidance.

For your convenience and to meet your educational needs, the AUA Annual Review Course offers your choice of course format.  The Live Course Only option includes in-person attendance in Austin, TX with live presentations, audience interaction, Q&A, practice questions, and more to come!  The Webcast Only option includes on-demand access to presentations on/after June 7.  This course does not offer a live stream option.


For the ABU Qualifying (Part 1) Examination, residents need to possess basic urologic knowledge and an understanding of current American Urological Association practice guidelines. To fulfill this need, the AUA developed this course to disseminate current urologic knowledge and successfully prepare residents for the ABU examination. This course is also of interest to practicing urologists as well as others, including allied health professionals, looking for a thorough review of basic urologic topics.


Attendees can choose between three options:

  1. Live Course Only
  2. Bundle the Live Course Only + Webcast Upgrade - Most Popular Option!*
  3. Webcast Only
  4. Printed Syllabus*

*The printed syllabus is an optional add-on available to Live Course Only registrants and is not included with either the Live Course Only, or Webcast Upgrade purchases. The printed syllabus may only be purchased in conjunction with the Live Course product.

Select our most popular option and bundle the Live Course Only AND Webcast Upgrade for access to the webcasts following the live event. 

AUA Guarantee: This course is backed by the AUA Guarantee: If you fail the boards, then we will pay for you to retake our in person course. (Applicable 2022 registrants please call 1-800-908-9414) 


Registration Fees

AUA Members save 25%!  For more information on membership benefits, visit www.AUAnet.org/Join.   

Early Bird Registration- On or before April 21, 2023 to save 25%

Membership Category

Live Course Only

Webcast Upgrade*

Webcast Only*

Printed Syllabus**

Now through May 5, 2023

Member$945$300$945$215
Non-Member$1180$300$1180
Member Resident/Allied$525$150$525
Non-Member Resident/Allied$655$150$655

Standard Registration- On or after April 22, 2023

Membership Category

Live Course Only

Webcast Upgrade*

Webcast Only*

Printed Syllabus**

Now through May 5, 2023

Member$1180$300$945$215
Non-Member$1475$300$1180
Member Resident/Allied$655$150$525
Non-Member Resident/Allied$820$150$655

*Webcasts will be available to view on Wednesday, June 7, 2023. (Applies to Webcast Only and Webcast Upgrade registrants)  

**The Annual Review Course Syllabus is a separate and optional add-on and available only to Live Course registrants. A limited supply will be available onsite at an increased charge.

Target Audience

  • Residents
  • Urologists

Learning Objectives

At the conclusion of this course, participants will be able to:

  1. Apply basic, generally accepted urological practices for effective, high-quality patient care.
  2. Demonstrate core knowledge of urology necessary for American Board of Urology (ABU) Qualifying (Part 1) Examination.
  3. Utilize AUA Guidelines for appropriate patient evaluation and management.
Course summary
Course opens: 
10/13/2022
Course expires: 
06/04/2026
Event starts: 
06/02/2023 - 7:00am EDT
Event ends: 
06/04/2023 - 5:00pm EDT
Price:
$1,475.00
Rating: 
0

Annual Review Course

Austin, TX
June 2–4, 2023

Scientific Program

Friday, June 2, 2023

6:30 a.m.Regristration/Breakfast
7:15 a.m.Introdution
Howard B. Goldman, MD, FACS and Kristen R. Scarpato, MD, MPH
ANATOMY AND EMBRYOLOGY 
7:30 a.m.Applied Anatomy
Embryology
Howard B. Goldman, MD, FACS
RENAL MEDICINE
9:15 a.m.Renal Physiology (including Fluid and Electrolytes)
Renal Transplantation
Renal Vascular Disease
Nick Cowan, MD
10:00 a.m.Break
TRAUMA AND RECONSTRUCTION
10:15 a.m.Renal and Ureteral Trauma and Reconstruction
Bladder and Urethral Trauma and Reconstruction
Genital Trauma: Evaluation and Management
Surgical Management of Male Incontinence
Jay Simhan, MD, FACS
ERECTILE DYSFUNCTION
11:30 a.m.Physiology of Erection, Pathophysiology of Erectile Dysfunction
Evaluation and Management of Erectile Dysfunction
Pathophysiology, Evaluation and Management of Priapism
Pathophysiology, Evaluation and Management of Peyronie’s Disease
Akanksha Mehta, MD, MS
12:30 p.m.Lunch*
PEDIATRIC UROLOGY
2:00 p.m.Congenital Urinary Tract Abnormalities
  • UPJ Obstruction, UVJ Obstruction (Megaureter)
  • Ureteroceles
  • Cystic Kidney Disease
  • Posterior Urethral Valves
  • Prune Belly Syndrome
  • Vesicoureteral Reflux
Bruce Schlomer, MD
PEDIATRIC UROLOGY
2:45 p.m.Pediatric Urinary Incontinence and Bladder Disorders
  • Voiding Dysfunction and Neurogenic Bladder
  • Developmental Anomalies of the Bladder
  • Urinary Tract Infection and Secondary Reflux
  • Management of Neurogenic and Non-Neurogenic Bladder
  • Pediatric Metabolic Stones
Armando Lorenzo, MD, FAAP, FACS, FRCSC, MSC
3:30 p.m.Break
3:45 p.m.Disorders of the Genitalia/Scrotum
  • Disorders of Sexual Differentiation
  • Hypospadias
  • Undescended Testicle
Bruce Schlomer, MD
4:15 p.m.Pediatric Urological Oncology
  • Wilms’ Tumor and Other Renal Tumors
  • Rhabdomyosarcoma
  • Neuroblastoma
  • Testis Tumors
Armando Lorenzo, MD, FAAP, FACS, FRCSC, MSC
4:45 p.m.Pediatric Review Questions
Armando Lorenzo, MD, FAAP, FACS, FRCSC, MSC
5:15 p.m.Meeting Adjourns
Saturday, June 3, 2022
6:30 a.m.Breakfast
TESTICULAR TUMORS
7:15 a.m.Timothy A. Masterson, MD
Epidemiology, Diagnosis, Staging, and Imaging (including the Role of Markers and CIS)
  • Treatment of Seminoma
  • Treatment of Non-Seminomatous Germ Cell Tumors (including Controversy Regarding Stage A Management, Risk Factors for Recurrence, Algorithms for Stages A,B, and C)
RENAL AND URETERAL TUMORS
8:15 a.m.Robert G. Uzzo, MD
  • Epidemiology, Anatomy, Diagnosis and Imaging (Including Evaluation of Renal Masses)
  • Treatment of Localized Disease (including Role of Partial Nephrectomy)
  • Treatment of Metastatic Disease
  • Transitional Cell Carcinoma
9:30 a.m.Break
PENILE AND URETHRAL CANCER
9:45 a.m.Robert G. Uzzo, MD
  • Epidemiology
  • Diagnosis and Staging
  • Imaging and Treatment 
BLADDER CANCER
10:30 a.m.Kristen R. Scarpato, MD, MPH
  • Epidemiology, Anatomy, Diagnosis and Imaging
  • Treatment of NMIBC/ Superficial Disease Management
11:15 a.m.Jennifer M. Taylor, MD, MPH
  • Staging and Risk Stratification of Muscle Invasive Bladder Cancer
  • Multidisciplinary Treatment including Radical Cystectomy, Lymphadenectomy, Peri-Operative Chemotherapy and Chemoradiation Therapy
  • Metabolic Derangements that Occur with Diversions
  • Other Bladder Sparing Treatments
  • Treatment of Metastatic Disease
12:15 p.m.Kristen R. Scarpato, MD, MPH & Jennifer M. Taylor, MD, MPH
Bladder Cancer Review Questions

 

12:30 p.m.Lunch
PROSTATE CANCER
2:00 p.m.Kristen R. Scarpato, MD, MPH
  • Diagnosis and Screen, Staging, Imaging (including PSA Screening Controversies)
  • Treatment of Localized Cancer (U.S. Stages A and B), Watchful Waiting, Radiation, Interstitial Irradiation, Surgery, Cryosurgery and Hormonal Therapy
  • Treatment of Advanced Cancer (U.S. Stages C and D) and Treatment of Radiation Failure
  • DVT Prophylaxis
LAPAROSCOPY
3:15 p.m.Alexander Kutikov, MD
Physiology and Complications
3:45 p.m.Break
INFERTILITY
4:00 p.m.Sarah C. Vij, MD
  • Physiology and Pathophysiology of Male Reproduction
  • Evaluation of the Infertile Male
  • Treatment of the Infertile Male (Surgical and Non-surgical)
  • Hypogonadism
  • Testosterone Replacement
5:30 p.m.Meeting Adjourns

Sunday, June 4, 2022

6:30 a.m.Registration/Breakfast
ADRENAL
7:15 a.m.Epidemiology, Diagnosis and Imaging (including Cushings, Hyperaldosteronism, Pheochromocytoma, Cancer and the Incidentally Found Adrenal Mass)
Management (including Pheochromocytoma, Cancer, Hyperaldosteronism, Incidentaloma and Metastatic Disease)
Alexander Kutikov, MD
GU RADIOLOGY
8:00 a.m.Basics of MR, CT, US, VCUG
Solid and Cystic Renal Masses (CT and MR)
Transitional Cell Carcinoma
Prostate MRI
Adrenal Imaging
Scrotal Imaging
Retroperitoneal Tumors
Radiation Basic Principles
Vinay Prabhu, MD, MS
FEMALE UROLOGY, FEMALE SEXUAL DYSFUNCTION, URODYNAMICS AND NEUROUROLOGY
9:00 a.m.Female Sexual Dysfunction
Neurourology
Anne P. Cameron, MD, FRCSC, FPMRS
10:00 a.m.Break
10:15 a.m.Overactive Bladder/Urgency Incontinence
Stress Urinary Incontinence
Pelvic Organ Prolapse
Urethral Diverticulum
Urinary Fistula
Howard B. Goldman, MD
11:30 a.m.Urodynamics
  • Basics
  • Tracing Review
Anne P. Cameron, MD, FRCSC, FPMRS & Howard B. Goldman, MD
NoonLunch
UROLITHIASIS
1:00 p.m.Epidemiology, Pathophysiology
Evaluation and Medical Management
Surgical Management of Stone Disease
Mantu Gupta, MD, FRCS
2:30 p.m.Break
URINARY TRACT INFECTION
2:45 p.m.Urinary Tract Infections
Michel A. Pontari, MD
INTERSTITIAL CYSTITIS AND SEXUALLY TRANSMITTED DISEASES
3:30 p.m.Interstitial Cystitis
Sexually Transmitted Diseases (Gonorrhea, Chlamydia, AIDS and others)
Anne P. Cameron, MD, FRCSC, FPMRS
BPH
4:00 p.m.Evaluation
Medical Management
Surgical Management
Michel A. Pontari, MD
4:45 p.m.Meeting Adjourns

*Friday and Saturday Lunch will include opportunities to participate in a wellness activity and/or Lunch with the Experts - both first come, first serve by sign up only

Hyatt Regency
208 Barton Springs Road
Austin, TX 78704
United States

For live course and live course + webcast upgrade registrants- see below hotel information. For webcast only registrants, your purchase is for virtual access to this course only.


To hold a reservation, a major credit card number must be provided.
$211 single/double occupancy. Make your reservation online or call 877-803-7534. Reference the Hyatt Regency Austin and the AUA Annual Review Course when making your reservation to receive the special group rate.

Cut-off Date: Friday, May 5, 2023. Once the AUA group block is full, which may be prior to the cut-off date, the AUA is unable to guarantee rooms at this rate or at this hotel.

Check-in: 4 p.m.
Check-out: 11 a.m.

 

TOURISM

There is never a dull moment in Austin, and Hyatt Regency Austin is close to everything. Take advantage of the Lady Bird Lake location situated along the Ann and Roy Butler Hike-and-Bike Trail, perfect for an evening run or biking with Austin’s B-cycles. Head over to 6th Street attractions, Rainey street entertainment and do some shopping down South Congress Street. There are endless dining options to enjoy in Austin with excellent barbecue, Tex-Mex and food trucks. 

Education Council Disclosures

PDF icon Education Council Disclosures_2022.pdf

COI Review Work Group Disclosures

PDF icon COI Review Work Group Disclosures_2022.pdf

AUA Office of Education Staff has nothing to disclose.

All relevant financial relationships have been mitigated.

Course Co-director(s)

Howard Goldman, MD, FACS

has a financial relationship (Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)) with sacramed;.
has a financial relationship (Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)) with Bluewind;.
has a financial relationship (Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)) with vensica;.
has a financial relationship (Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)) with Boston Scientific;.
has a financial relationship (Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)) with allergan;.
has a financial relationship (Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)) with Direx;.
has a financial relationship (Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)) with Laborie;.
has a financial relationship (Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)) with Medtronic;.
has a financial relationship (Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)) with urovant;.
has a financial relationship (Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)) with NewUro;.
has a financial relationship (Consultant or Advisor (General Urology)) with Astellas;.

Kristen Scarpato, MD,FACS,MPH

has a financial relationship (Consultant or Advisor (Oncology)) with Optum;.
has a financial relationship (Meeting Participant or Lecturer (Oncology)) with Photocure;.
has a financial relationship (Consultant or Advisor (Oncology)) with CxBladder;.
Faculty(s)

Nicholas Cowan, MD

has no relevant financial relationships to disclose at this time.

Mantu Gupta, MD,FRCS

has a financial relationship (Consultant or Advisor (Specialty Not Specified)) with Olympus;.
has a financial relationship (Meeting Participant or Lecturer (Specialty Not Specified)) with Boston Scientific Inc;.
has a financial relationship (Meeting Participant or Lecturer (Specialty Not Specified)) with Retrophin Inc;.
has a financial relationship (Meeting Participant or Lecturer (Specialty Not Specified)) with Cook Urological;.

Alexander Kutikov, MD

has no relevant financial relationships to disclose at this time.

Armando Lorenzo, MD, FAAP, FACS, FRCSC, MSC

has no relevant financial relationships to disclose at this time.

Timothy Masterson, MD

has no relevant financial relationships to disclose at this time.

Akanksha Mehta, MD

has a financial relationship (Other (Male Infertility)) with Posterity Health;.

Anne Pelletier Cameron, MD

has a financial relationship (Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)) with Axonics;.
has a financial relationship (Health Publishing (Female Pelvic Medicine & Reconstructive Surgery)) with Springer;.
has a financial relationship (Health Publishing (Female Pelvic Medicine & Reconstructive Surgery)) with Wiley;.
has a financial relationship (Other (Female Pelvic Medicine & Reconstructive Surgery)) with Wellspect;.

Michel Pontari, MD

has no relevant financial relationships to disclose at this time.

Vinay Prabhu, MD, MS

has a financial relationship (Investment Interest (General Urology)) with Abbvie;.
has a financial relationship (Investment Interest (Non-urology Healthcare Related)) with QIAGEN;.
has a financial relationship (Investment Interest (Non-urology Healthcare Related)) with Sanofi;.
has a financial relationship (Investment Interest (Non-urology Healthcare Related)) with Moderna;.
has a financial relationship (Investment Interest (Oncology)) with Gilead;.

Bruce Schlomer, MD

has no relevant financial relationships to disclose at this time.

Jay Simhan, MD,FACS

has a financial relationship (Meeting Participant or Lecturer (Erectile Dysfunction)) with Boston Scientific ;.
has a financial relationship (Meeting Participant or Lecturer (Erectile Dysfunction)) with Coloplast;.

Jennifer Taylor, MD,MPH

has a financial relationship (Scientific Study or Trial (Oncology)) with Photocure Inc;.
has a financial relationship (Health Publishing (Oncology)) with Demos Medical Publishing;.

Robert Uzzo, MD,CEO,MBA

has a financial relationship (Consultant or Advisor (Oncology)) with UroGen Pharma;.
has a financial relationship (Scientific Study or Trial (Oncology)) with Merck;.
has a financial relationship (Other (Oncology)) with Pfizer;.

Sarah Vij, MD

has no relevant financial relationships to disclose at this time.
COI Reviewer(s)

Jody Donaldson,

has no relevant financial relationships to disclose at this time.

AUA ACCREDITATION INFORMATION

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this live and enduring activity for a maximum of 24.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

MITIGATION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:

  • Peer review for valid, evidence-based content by the AUA COI Review Work Group.
  • Attestation that clinical recommendations are evidence-based and free of commercial bias.
  • Introduction of a debate format (point-counterpoint)
  • Inclusion of moderated panel discussion with unbiased moderator
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Divestiture of the relationship by faculty
  • Recusal from controlling relevant aspects of planning
  • Selection of alternative faculty for specific topic

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

 
Status
Price
Title
$1,475.00Included
Please login or register to take this course.
$1,475.00Included
Please login or register to take this course.
$300.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$215.00Included
Please login or register to take this course.

Price

Price:
$1,475.00
Please login or register to take this course.

NOTES:

  • Attendees must purchase the Annual Review Course Live Course Only to purchase the printed syllabus.  
  • All syllabi will be picked up onsite at the registration desk.

Early Bird Registration - On or before April 21, 2023 to save 25%

Membership Category

Live Course Only

Webcast Upgrade*

Webcast Only*

Printed Syllabus**

Now through May 5, 2023

Member$945$300$945$215
Non-Member$1180$300$1180
Member Resident/Allied$525$150$525
Non-Member Resident/Allied$655$150$655

Standard Registration- On or after April 22, 2023

Membership Category

Live Course Only

Webcast Upgrade*

Webcast Only*

Printed Syllabus**

Now through May 5, 2023

Member$1180$300$945$215
Non-Member$1475$300$1180
Member Resident/Allied$655$150$525
Non-Member Resident/Allied$820$150$655


*Webcast will be available to view on Wednesday, June 7, 2023.

**Attendees must purchase the Annual Review Course Live Course Only to purchase the printed syllabus. Pre-ordered syllabi will be picked up onsite at registration. A limited supply will be available for purchase onsite for those who would like a syllabus but did not pre-order.


CANCELLATION POLICY

Live Course: An administrative fee of 15% is assessed if registration is cancelled up to six weeks prior to the course. If registration is cancelled four to six weeks from the course, the cancellation fee is 50% of the registration fee paid. No registration fees will be refunded less than four weeks prior to the course. In the event that the Live Course converts from live in-person to a live virtual course, all registrations will be converted to the live virtual course and no full refunds will be issued. The Cancellation Policy will apply. The AUA cannot be held responsible for other costs or expenses, including cancellation/change penalties assessed by airlines, travel agencies or hotels.

Syllabus: No syllabus refunds will be given after May 5, 2023.

Webcast: Cancellations must be made no later than one week prior to the live course. Subscription fees will not be refunded after the cancellation period. Purchases after the live course date are not eligible for a refund.

Registration Transfer: Customers switching from an option of lesser value to a higher value will be required to pay the difference in cost between the two options. Switching to an option of lesser value from a higher value must be made no later than to six weeks prior to the course and will be subject to an administrative fee of 15% of the cost of the course from which they are transferring. Transfer of registration from a higher value option to an option of lesser value past six weeks prior to the course will not receive a refund.

Cancellations must be made in writing. Requests may be made via mail or fax to 410-689-3912.  Questions? Call 1-800-908-9414 or email registration@AUAnet.org.

AUA Education & Research reserves the right to cancel this course if a minimum enrollment is not reached before April 28, 2023. If AUA Education & Research cancels this course, notification will be sent by May 5, 2023.


ATTENDEE INFORMATION & POLICIES

AUA Anti-Harassment Policy: AUA Commitment: AUA is committed to providing a safe and productive meeting environment that fosters open dialogue and the exchange of scientific ideas and is free of harassment and discrimination. All meeting participants are expected to behave professionally and treat others with respect, follow venue rules, and alert AUA staff or security of any dangerous situations or anyone in distress.

Reporting Harassment: It is the policy of the AUA that all meeting participants will enjoy an environment free from discrimination, harassment or retaliation. Harassing or offensive behavior by meeting participants will not be tolerated. If an individual experiences or witnesses harassment, he or she should contact Janet Skorepa, AUA EVP, at jskorepa@AUAnet.org or use a venue phone and ask for security if he or she feels unsafe. All complaints will be treated seriously and responded to promptly.

The AUA reserves the right to take any action deemed necessary and appropriate, including refusing or revoking the registration of any individual, without refund, as long as such refusal is consistent with applicable law and AUA policy.

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the American Urological Association (AUA).

Consent to Use of Photographic Images: Registration and attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

Audio, Video, Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the AUA.

Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, a written request should be submitted at least one month in advance. For additional assistance with your request please call 1-800-908-9414.